CSI Market
Sign In | Register

Cogent Biosciences Inc (COGT) Annual Balance Sheets

Annual · GAAP · USD millions
Access COGT quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Cogent Biosciences Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent312.01
Available-for-sale Securities, Debt Securities, Current MA588.75
Cash & Short-term Investments900.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.59
Total Current Assets910.36
Equipment/Property/Plant Net5.46
Long-term investments0.00
Other Assets, Noncurrent21.80
Restricted Cash Current0.00
Operating Lease Right Of Use Asset18.08
Restricted Cash Noncurrent0.42
Total Assets937.61
Liabilities
Accounts Payable, Current AC9.50
Other Liabilities, Current54.45
Total Current Liabilities63.95
Convertible Debt, Noncurrent LO222.90
Total Long-term Debt222.90
Other liabilities, Noncurrent14.39
OperatingLeaseLiabilityNoncurrent14.36
Accrued Expenses And Other Liabilities Current52.90
Total Liabilities301.24
Stockholders' Equity
Common Stock Value0.16
Additional Paid In Capital Common Stock1,734.88
Retained Earnings / Accumulated Deficit-1,188.42
Other Equity89.75
Common Stockholder's Equity636.37
Preferred Stockholder's Equity0.00
Total Stockholder's Equity636.37
Liabilities & Stockholder's Equity937.61
4 historic quarters locked

Sign in to unlock the full Cogent Biosciences Inc balance sheet history.

Sign In Create Free Account

About Cogent Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: cogt-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-053334

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License